Page
%P
-
Article
Open AccessCorrection to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
Following publication of the original article [1], the authors reported an error in Fig. 1f.
-
Article
Open AccessA reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
To reveal roles of reactive oxygen species (ROS) status in chemotherapy resistance and to develop a ROS scoring system for prognosis prediction in ovarian cancer.
-
Article
Open AccessCytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer
P21(WAF1/Cip1) binds to cyclin-dependent kinase complexes and inhibits their activities. It was originally described as an inhibitor of cancer cell proliferation. However, many recent studies have shown that p21 ...